Savara
SVRA
#6350
Rank
NZ$1.69 B
Marketcap
NZ$8.29
Share price
-1.89%
Change (1 day)
10.81%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -NZ$0.25 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.22 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.25 Billion14.61%
2025 -NZ$0.22 Billion23.94%
2024 -NZ$0.18 Billion75.29%
2023 -NZ$97.32 Million43.38%
2022 -NZ$67.88 Million-11.31%
2021 -NZ$76.54 Million-13.3%
2020 -NZ$88.28 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.13 Billion105.54%
2017 -NZ$59.49 Million34.11%
2016 -NZ$44.36 Million-37.43%
2015 -NZ$70.89 Million38.81%
2014 -NZ$51.07 Million33.62%
2013 -NZ$38.22 Million38.49%
2012 -NZ$27.6 Million24.59%
2011 -NZ$22.16 Million-36.5%
2010 -NZ$34.89 Million-3.14%
2009 -NZ$36.02 Million-23.28%
2008 -NZ$46.94 Million8.52%
2007 -NZ$43.26 Million-34.14%
2006 -NZ$65.68 Million184.43%
2005 -NZ$23.1 Million90.75%
2004 -NZ$12.11 Million190.35%
2003 -NZ$4.17 Million11.64%
2002 -NZ$3.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.15 Billion-42.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.31 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA